FDA-approved artificial intelligence and machine learning (AI/ML)-enabled medical devices: an updated landscape

G Joshi, A Jain, SR Araveeti, S Adhikari, H Garg… - Electronics, 2024 - mdpi.com
As artificial intelligence (AI) has been highly advancing in the last decade, machine learning
(ML)-enabled medical devices are increasingly used in healthcare. In this study, we …

New2Neuropsychology (N2N): An organization to promote diversity, equity, and inclusion in neuropsychology

TR Schmitt, R Van Patten… - The Clinical …, 2024 - Taylor & Francis
Abstract Objective To introduce New2Neuropsychology (N2N), an organization that seeks to
increase recruitment of historically underrepresented minoritized (URM) students, and to …

Are community oncology practices with or without clinical research programs different? A comparison of patient and practice characteristics

I Altomare, X Wang, M Kaur, JS Guadamuz… - JNCI Cancer …, 2024 - academic.oup.com
Background Expanding access to clinical trials in community settings is a potential approach
to addressing disparities in accrual of historically underrepresented populations. However …

Sex or gender reporting in ophthalmology clinical trials among US Food and Drug Administration approvals, 1995 to 2022

JS Xie, H Kaur, B Tao, J Lee, D Solish… - JAMA …, 2024 - jamanetwork.com
Importance As critical determinants of scientific rigor, reproducibility, and equity, sex and
gender should be considered in clinical trial design and reporting. Objective To evaluate the …

Factors Associated With Minority Patient Enrollment in a Gastric Cancer Biobank

MF Pettigrew, AI Al Abbas, A Southichack… - Journal of Surgical …, 2025 - Elsevier
Introduction Human tissue samples are essential for translational cancer research. However,
less than 20% of current biobank and genomic samples were obtained from minority …

[HTML][HTML] Examining recollections of Black women with breast cancer who participated in clinical trials: A grounded practical theory study of patient-provider …

KE Ridley-Merriweather, OP Okoruwa… - Contemporary Clinical …, 2024 - Elsevier
The presence of strong barriers to research participation for Black women is indisputable.
However, existing evidence supports the possibility of equal levels of participation among …

[HTML][HTML] Latest CISCRP Patient Survey Reveals Diversity Gaps, Yields 5 Tips For Improve-ment

A de Bruin - Clinical Leader, 2024 - ciscrp.org
Despite the FDA introducing a draft guidance document two years ago that outlined
strategies to improve minority representation in clinical trials, 4 recent studies suggest that …

Training Clinical Scientists: At All Career Stages

AL Hartman, LA Weigand, SJ Korn, CB Wright - Neurology, 2024 - neurology.org
Almost daily, results from clinical studies are published in the popular press. A highly
qualified workforce is needed to design and implement these studies. Formal training in …

Psychosocial Factors That Influence a Woman's Decision to Enroll in a Clinical Trial: Implications on How to Improve Clinical Trial Enrollment Among Black Women

U Markan, K Baker, C Eggleston, SB Cheston… - International Journal of …, 2024 - Elsevier
Purpose Black women with breast cancer often present with more aggressive disease
compared with other races, contributing to an increased risk of cancer mortality. Despite this …

Perspectives on Inclusion, Diversity, Equity, and Access in Clinical Trials: Findings from a Six-Continent Survey

D Dimitrova, J Boer, M Karaman, M Bookman… - International Journal of …, 2025 - Elsevier
Objective Clinical trials necessitate the inclusion of all relevant demographic groups,
including underrepresented populations, to ensure accurate and representative findings …